Study Reveals Care Delays in Young Women with Breast Cancer
Research highlights demographic and tumor factors causing delays in breast cancer treatment for women under 40, though outcomes remain unaffected.
153 presentation delays and 120 diagnostic delays identified in the study.
Lower income linked to higher odds of care delays; pregnancy and family history linked to lower odds.
No significant impact of delays on disease-free or overall survival rates.
A recent study published on October 12 in the journal Cancer has uncovered significant delays in care for young women diagnosed with breast cancer. Conducted by Dr. Bessie X. Zhang and her team at Brigham and Women’s Hospital in Boston, the research focused on women aged 40 and younger diagnosed with stages 0 to IV breast cancer. The study aimed to identify the factors contributing to these delays and assess their impact on patient outcomes.
The researchers analyzed data from 1,071 women and found a total of 153 presentation delays, defined as the time from the first symptom to the provider visit, lasting 90 days or more. Additionally, there were 120 diagnostic delays, which occurred from presentation to diagnosis, and 228 treatment delays from diagnosis to treatment. The study revealed that lower annual income was associated with a higher likelihood of presentation delays, while factors such as pregnancy at diagnosis and a family history of breast cancer were linked to lower odds of delays.
Further analysis indicated that younger patients experienced higher odds of diagnostic delays, while those with triple-negative tumors had lower odds. Treatment delays were less common among patients with more aggressive tumor subtypes. Importantly, the study found no significant associations between these delays and disease-free survival or overall survival rates, suggesting that while delays are prevalent, they do not adversely affect long-term outcomes.
The implications of these findings are significant for public health and oncology practices. The study highlights the need for improved awareness among both patients and healthcare providers regarding the risk factors and symptoms of breast cancer in younger women. By addressing these gaps, healthcare systems can work towards reducing the burden of disease and improving timely access to care for this vulnerable population.
Looking ahead, the researchers emphasize the importance of ongoing education and advocacy to enhance understanding of breast cancer in young women. Future studies may explore additional strategies to mitigate delays in care and improve overall health outcomes for this demographic.
